Singapore markets close in 5 hours 47 minutes

I-MAB (0VY.DU)

Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
1.59000.0000 (0.00%)
At close: 07:56PM CEST
Full screen
Previous close1.5900
Open1.5800
Bid1.5800 x N/A
Ask1.6500 x N/A
Day's range1.5800 - 1.6100
52-week range1.5800 - 1.7300
VolumeN/A
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date15 Aug 2024 - 19 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Thomson Reuters StreetEvents

    Q1 2024 Summit Therapeutics Inc Earnings Call

    Q1 2024 Summit Therapeutics Inc Earnings Call

  • PR Newswire

    I-MAB Filed 2023 Annual Report on Form 20-F

    I-Mab (the "Company") (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that it has filed its annual report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC") on April 30, 2024.